Golimumab Subcutaneous and M-End Max D
Determining the interaction of Golimumab Subcutaneous and M-End Max D and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: golimumab
Brand name: Simponi, Simponi SmartJect, Simponi Aria
Synonyms: Golimumab
Generic Name: codeine / dexbrompheniramine / pseudoephedrine
Brand name: M-End Max D
Synonyms: n.a.
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Golimumab Subcutaneous-M-End PE
- Golimumab Subcutaneous-M-End WC
- Golimumab Subcutaneous-M-Hist DM
- Golimumab Subcutaneous-M-Hist PD
- Golimumab Subcutaneous-M-M-R II
- Golimumab Subcutaneous-M-M-R II Vaccine
- M-End Max D-GoLYTELY
- M-End Max D-Gonadorelin
- M-End Max D-Gonadorelin Intravenous, Injection
- M-End Max D-Gonadotropin, Chorionic
- M-End Max D-Gonal-F
- M-End Max D-Gonal-f RFF